AI x bio's wild week: phage therapy patient, toxin binders, OpenAI acquisition
HealthcareAIGuy · x · 2026-10-23
A roundup of a packed week for AI in biology:
- Radical Numerics: Omnii-1 designed phages given to a human patient
- Claude: 17 scorpion-toxin binders validated in the lab
- OpenAI: acquired Orchestra Bio; agents with PerturbAI found new neurodegeneration leads in 32 minutes
- Open-source releases: programmable protein design model RFD4-Proteina and biomolecular simulation model BioEmu2
- Chaperone: a new agent framework for bio
From an actual patient treated with AI-designed phages to open protein design models, AI-driven biology is moving from papers into the real world.
Related event: AI×Bio Week: AI-Designed Phage Used in Human Patient for First Time(4 posts)→
More from Companies & People
- Shanghai hospital's doctor-built Med-Go LLM now spans 46 community centers and 30+ hospitals — nordicinst · 2026-10-23
- Google job listing hints at AI-native sharing that could kill URL-based SEO attribution — 5le · 2026-10-23
- Autodesk CEO: The Bigger AI Opportunity Is Connected Intelligence Across Design, Make and Operate — amcafee · 2026-10-23
- Humanities dissertations have collapsed, social sciences are next — with AI as one driver — gsiemens · 2026-10-23
- For consumer AI founders, 'When are you launching in Europe?' is the new 'When Android?'—only 100x worse — omooretweets · 2026-10-23
- Lilian Weng to Discuss Recursive Self-Improvement at SGLang Summit 2026 — BanghuaZ · 2026-10-23